Revvity, Inc., which trades on the NYSE under the ticker RVTY, has launched its newest software, Living Image Synergy AI, aimed at helping researchers who work with in vivo imaging. This new software is a single platform that uses artificial intelligence to analyze data from multiple imaging techniques, such as optical imaging, microCT, ultrasound, and others. The main goal of this solution is to reduce data inconsistencies, simplify the analysis process, improve efficiency, and boost reproducibility, all of which help to speed up scientific research and discovery.
Health Technology Insights: Myriad and SOPHiA Partner on Liquid Biopsy Diagnostic Tool
Kevin Quick, Vice President of platforms at Revvity, called the new software a significant breakthrough in preclinical imaging analysis. He explained that tracking and visualizing biological processes and disease progression is vital for understanding complex biological systems and testing new treatments at an early stage. By combining various analysis tools into one unified platform and integrating AI, the software aims to give researchers quicker insights, consistent analysis across different imaging methods, and better reproducibility between studies, helping scientists work more efficiently and with more confidence.
Health Technology Insights: Ultromics Study Shows AI Could Improve Early Detection of Cardiac Amyloidosis
Living Image Synergy AI was created to remove the need for multiple separate tools by bringing all analysis functions into one centralized platform. This integration enables researchers to uncover important biological information that might be overlooked when using isolated systems. The software also includes user-friendly co-registration tools and automated features that cut down on manual work and save time during analysis.
The platform’s advanced AI capabilities automate complex processes like image segmentation and region-of-interest quantification, which can be time-consuming and subject to variability. These improvements support high-volume analysis, making it easier for researchers to monitor disease progression and assess treatment effectiveness with increased accuracy and reliability.
Revvity plans to officially showcase Living Image Synergy AI at the upcoming World Molecular Imaging Congress (WMIC) in Anchorage, Alaska, from September 29 to October 3, 2025, where attendees can explore the software’s full range of features.
Health Technology Insights: Sidecar Health Partners with Carrum Health for Centers of Excellence
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
